MVIR:STO
Medivir AB
SEK 1.74
0.00%
(0.00) 1D
9-р сарын 15, 17:29:38 (GMT+2) · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Mkt. cap
1.09 тэрбум
Avg. vol.
1.87 сая
Volume
0.00
52-wk high
SEK 2.88
52-wk low
SEK 0.34
EPS
-SEK 0.37
Shares outstanding
624.04 сая
No. of employees
6
Mkt. cap
1.09 тэрбум
Avg. vol.
1.87 сая
Volume
0.00
52-wk high
SEK 2.88
52-wk low
SEK 0.34
EPS
-SEK 0.37
Shares outstanding
624.04 сая
No. of employees
6
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB